Featured Research

from universities, journals, and other organizations

Hormone discovered that preserves insulin production and beta cell function in diabetes

Date:
July 2, 2012
Source:
Duke University Medical Center
Summary:
Researchers have found protective, anti-diabetic functions for a hormone that, like insulin, is produced by the islet cells of the pancreas. The new hormone was found to stimulate insulin secretion from rat and human islet cells and protect islet cells in the presence of toxic, cell-killing factors used in the study.

Researchers at Duke University Medical Center have found protective, anti-diabetic functions for a hormone that, like insulin, is produced by the islet cells of the pancreas. The new hormone was found to stimulate insulin secretion from rat and human islet cells and protect islet cells in the presence of toxic, cell-killing factors used in the study.

The study, which was supported in part by JDRF, a global leader in type 1 diabetes research, appears in the July 3 issue of the journal Cell Metabolism.

The findings provide insight into the health and survival of beta cells, a type of islet cell that produces insulin to regulate sugar levels. The discovery could open pathways for further research toward prevention and treatments for type 1 diabetes and type 2 diabetes.

The researchers gave the hormone, TLQP-21 to Zucker Diabetic Fatty rats, which have a genetic propensity to develop type 2 diabetes. They saw a significant improvement in insulin and glucose (sugar) levels and less beta cell death in the treated animals.

"We think this finding is important because it is the first demonstration that TLQP-21 prevents deterioration of the beta cells and stimulates insulin secretion in the presence of glucose," said senior author Christopher B. Newgard, Ph.D., director of the Sarah W. Stedman Nutrition and Metabolism Center, and the W. David and Sarah W. Stedman Distinguished Professor. "Because diabetes starts to take hold when the number of beta cells dwindles and insulin production drops, finding the best way to produce more of this protective hormone could be valuable."

Although the researchers have so far only tested TLQP-21 in models of type 2 diabetes, they plan to test thehormone in type 1 in future studies.

Both types of diabetes are characterized by a loss of functional beta cell mass. Type 1 is an autoimmune disease characterized by selective and progressive loss of functional insulin-producing beta cells and is more severe. Type 2 is a disease characterized by beta cell dysfunction as well as peripheral insulin resistance. Most people with type 2 eventually become insulin-dependent.

"These exciting findings provide novel insight into how beta cell health and survival may be regulated in the body," said Patricia Kilian, Ph.D., director of the beta cell regeneration program at JDRF. "We are looking forward to studies that will further test how this novel hormone affects beta cell function in T1D (type 1 diabetes) models."

TLQP-21 is similar in some of its functions to another naturally occurring hormone produced in the digestive tract, glucagon-like peptide-1 (GLP-1). Through different mechanisms, both hormones protect and promote insulin secretion. GLP-1 or drugs that stabilize it are widely used to treat type 2 diabetes, but with some side effects, including increased heart rate and reduced stomach emptying; the effect on intestinal function has caused some people to stop the therapy.

The next step is to find a small molecule that could stimulate the islet cells to produce more of the TLQP-21 hormone, or to develop more potent or stable versions of injected hormone. Research toward a longer-acting drug will help accelerate its eventual testing in type 1 diabetes, said Newgard, who is also a professor of Pharmacology and Cancer Biology.

The work was a collaboration with Geoffrey Pitt, M.D., Ph.D., an associate professor of medicine in cardiology who heads the Duke Ion Channel Research Unit, and Albert Y. Sun, M.D., a cardiovascular disease fellow in the Pitt lab, who ran the tests to determine whether TLQP-21 raised heart rates. Other authors of the study include Jonathan C. Schisler, Ph.D., Hans E. Hohmeier, M.D., Ph.D., and Jie An, Ph.D.

The work was supported by grants from the JDRF, the National Institutes of Health (DK58398), and an American Heart Association post-doctoral fellowship, as well as a sponsored research agreement with Eli Lilly, with whom Dr. Newgard consults.


Story Source:

The above story is based on materials provided by Duke University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Duke University Medical Center. "Hormone discovered that preserves insulin production and beta cell function in diabetes." ScienceDaily. ScienceDaily, 2 July 2012. <www.sciencedaily.com/releases/2012/07/120702162319.htm>.
Duke University Medical Center. (2012, July 2). Hormone discovered that preserves insulin production and beta cell function in diabetes. ScienceDaily. Retrieved September 17, 2014 from www.sciencedaily.com/releases/2012/07/120702162319.htm
Duke University Medical Center. "Hormone discovered that preserves insulin production and beta cell function in diabetes." ScienceDaily. www.sciencedaily.com/releases/2012/07/120702162319.htm (accessed September 17, 2014).

Share This



More Health & Medicine News

Wednesday, September 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com
Obama Orders Military Response to Ebola

Obama Orders Military Response to Ebola

AP (Sep. 16, 2014) Calling the Ebola outbreak in West Africa a potential threat to global security, President Barack Obama is ordering 3,000 U.S. military personnel to the stricken region amid worries that the outbreak is spiraling out of control. (Sept. 16) Video provided by AP
Powered by NewsLook.com
UN: 20,000 Could Be Infected With Ebola by Year End

UN: 20,000 Could Be Infected With Ebola by Year End

AFP (Sep. 16, 2014) Nearly $1.0 billion dollars is needed to fight the Ebola outbreak raging in west Africa, the United Nations say, warning that 20,000 could be infected by year end. Duration: 00:40 Video provided by AFP
Powered by NewsLook.com
Obama: Ebola Outbreak Threat to Global Security

Obama: Ebola Outbreak Threat to Global Security

AP (Sep. 16, 2014) President Obama is ordering U.S. military personnel to West Africa to deal with the Ebola outbreak, which is he calls a potential threat to global security. (Sept. 16) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

      Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins